Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Arkis Biosciences
The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the final day of the meeting.
As the news breaks that UK big pharma AstraZeneca has rejected a final takeover bid from US giant Pfizer, several of both the firms' smaller pharma and biotech partners will be breathing a sigh of relief.
As the Pfizer, AstraZeneca megamerger circus continues following meetings between UK government committees and both companies' chiefs executives (scripintelligence.com, 15 May 2014), Scrip has been investigating possible repercussions a takeover could have on the giant drug makers' smaller pharma and biotech partners.
- Implantable Devices
- Surgical Equipment & Devices
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.